Discontinuation of immunosuppression in patients with immune‐mediated drug‐induced liver injury or idiopathic autoimmune hepatitis: A case–control study

Discontinuation of immunosuppression in patients with immune‐mediated drug‐induced liver injury or idiopathic autoimmune hepatitis: A case–control study

Abstract Background and Aim Drug‐induced liver injury (DILI) may present with autoimmune features and require immunosuppressive therapy (IST) to reach biochemical response. Discontinuation of IST without hepatitis relapse may be more frequent in these patients as compared to patients with classical...

Full description

Bibliographic Details
Main Authors: Jeremy Hassoun, Nicolas Goossens, Sophie Restellini, Lucas Ramer, Marie Ongaro, Emiliano Giostra, Antoine Hadengue, Laura Rubbia‐Brandt, Laurent Spahr
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:JGH Open
Subjects:
autoantibody
gamma globulins
histological damage
immune‐mediated drug‐induced liver injury
liver biopsy
transaminases
Online Access:https://doi.org/10.1002/jgh3.12862

Similar Items

Similar Items